Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has helped millions lose weight, yet clinical trials show response rates vary widely—from modest results to dramatic transformations. Not everyone loses weight at the same pace or achieves identical outcomes, even when taking the same medication at comparable doses. This variability stems from biological differences that science is only beginning to fully understand.
Why Semaglutide Weight Loss Outcomes Differ Between People
Semaglutide works by slowing stomach emptying and signaling fullness to the brain through the GLP-1 receptor pathway. However, the strength and efficiency of this pathway varies from person to person based on genetics, existing metabolic conditions, lifestyle factors, and previous weight loss attempts. Someone with a more responsive GLP-1 receptor system may experience pronounced appetite suppression within days, while another individual might need several weeks to feel similar effects.
Body composition at baseline also influences outcomes. People beginning treatment with higher insulin resistance often see faster initial weight loss as their metabolism becomes more efficient. Conversely, those with lower baseline insulin levels may experience more gradual changes. Age, activity level, sleep quality, and stress management all interact with semaglutide's effects on hunger and energy expenditure.
Genetic Factors That Shape Your Semaglutide Response
Your DNA contains genes that directly control how effectively you respond to GLP-1 medications. The GLP1R gene (particularly the rs6923761 variant) influences how sensitive your cells are to semaglutide signals. Someone inheriting variants that enhance GLP-1 receptor function may feel fuller faster and maintain weight loss more easily. Conversely, less favorable variants might require higher doses or longer treatment duration to achieve the same results.
Other genetic pathways amplify or diminish semaglutide's impact. The FTO gene (rs9939609) affects how your body regulates energy storage and appetite centers in the brain. The MC4R gene (rs17782313) controls melanocortin signaling, which governs hunger and metabolic rate. The GIPR receptor (rs1800437) works alongside GLP-1 to regulate blood sugar and appetite. PlexusDx maps these four key variants plus 45 additional peptide-related genes to predict how your body will respond before starting therapy.
How Precision Genetic Testing Predicts Your Weight Loss Potential
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights related to GLP-1 response, appetite regulation, and weight management. This test examines whether your genetics favor strong semaglutide sensitivity, moderate response, or a pattern that might benefit more from dual-compound therapies like tirzepatide. Testing occurs after your first month of treatment, allowing PlexusDx clinical teams to refine your medication choice and dosing strategy based on both your genetics and early clinical response.
Genetic insight doesn't guarantee outcomes but dramatically improves the odds of finding your optimal therapy faster. A patient with genetic markers predicting lower GLP-1 receptor sensitivity might benefit from starting semaglutide's slightly higher dose tier or considering tirzepatide's dual-action mechanism. Conversely, someone with highly favorable genetic markers may achieve goals at the lowest pricing tier, aligning therapy intensity with biological need.
Non-Genetic Reasons Weight Loss Plateaus or Varies
Even genetically ideal candidates experience weight loss plateaus—a completely normal adaptation where the body adjusts to medication after several months. At this point, maintaining your loss requires consistent nutrition habits and regular movement, not necessarily medication adjustments. Some patients benefit from structured behavioral support, dietary counseling, or increasing exercise intensity to push past plateaus without medication changes.
Medication adherence significantly affects results. Missing doses, inconsistent injection timing, or improper injection technique reduces semaglutide's effectiveness. Dietary choices matter too: semaglutide suppresses appetite but doesn't prevent overeating high-calorie foods if portion control lapses. Sleep deprivation, chronic stress, and certain medical conditions (thyroid dysfunction, hormonal imbalances, medications like antipsychotics) can slow or stall weight loss despite perfect medication compliance.
Choosing Between Semaglutide and Tirzepatide Based on Your Profile
For patients whose genetic testing reveals strong GLP-1 pathway sensitivity and no markers suggesting dual-pathway advantage, compounded semaglutide injection (starting at $149/mo) provides straightforward, highly effective therapy. PlexusDx's flat-rate pricing means your dose may increase without your monthly cost changing—a transparent approach to personalized care without surprise price escalations.
Patients with genetic variants predicting lower single-pathway response may benefit from tirzepatide, which activates both the GLP-1 and GIP receptors for broader metabolic effects. PlexusDx offers compounded tirzepatide injection starting at $249/mo. Some patients discover their optimal outcome through dual-compound GLP-Squared Injection (semaglutide and tirzepatide combined) starting at $249/mo, a strategy particularly useful when genetic testing identifies multi-pathway involvement in weight regulation.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
If someone I know lost 40 pounds on semaglutide, why might I lose only 15 pounds?
Your genetics, starting body composition, metabolic health, lifestyle adherence, and previous diet history all influence results. Semaglutide is highly effective for most people, but 'effective' means different amounts of weight loss for different bodies. PlexusDx's Precision Peptide Genetic Test identifies your genetic profile to predict realistic outcomes and optimize your specific medication choice.
What does a clinical trial say about semaglutide's real-world effectiveness?
The STEP trials showed average weight loss of 10-22% of body weight over 68 weeks, but individual results ranged from minimal loss to 30%+ reductions. Approximately 70% of participants achieved at least 5% weight loss, while roughly 50% achieved 15% or greater loss. These variations underscore why personalized assessment matters more than population averages.
How much does PlexusDx semaglutide cost and do I need insurance?
PlexusDx compounded semaglutide injection starts at $149/mo with no insurance required and no membership fees. The medication is HSA/FSA eligible. Your dose may increase during treatment, but your monthly price remains flat across all commitment tiers—transparent, predictable, and accessible nationwide.
Is compounded semaglutide as safe as brand-name Ozempic?
PlexusDx sources all medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight and quality standards. While compounded medications are not FDA-approved (unlike brand Ozempic), they maintain pharmaceutical-grade purity, potency, and sterility. Safety profiles are comparable; side effects such as nausea, constipation, and appetite suppression follow similar patterns.
How does the Precision Peptide Genetic Test help predict my weight loss success?
The test analyzes your GLP1R, FTO, MC4R, GIPR variants plus 45 additional genes across 14 metabolic pathways. Results reveal whether your biology favors strong semaglutide response, moderate sensitivity, or potential benefit from dual-compound therapy. This insight, combined with your early clinical response, helps PlexusDx clinicians optimize your medication and dosing strategy for maximum results. The test costs $99 as an add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Lose Weight on 2.5 Semaglutide? A Comprehensive Guide
Do You Have to Take Ozempic Forever for Weight Loss? Understanding the Long-Term Use of GLP-1 Medications